HRTX
Heron Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.29 / 10
Netural
Fund flow evaluation scores 7.82/10, reflecting robust inflows, especially at small and medium levels. Despite an overall negative trend, positive small and medium inflows suggest accumulation by institutional investors. Among analysts, HC Wainwright maintains a Strong Buy rating with a 50% historical win rate, but the limited sample size restricts confidence. Combined, the sentiment is neutral with a slight positive bias from fund flows.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-09
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for HRTX?
- HRTX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.29/10 (Netural).
